| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Op-ed: Is blockchain the technology that’s going to fix healthcare’s many problems? Potentially. But not now. Not even close. Before we can fix healthcare with blockchain, we need to break down the barriers that are preventing blockchain from fixing healthcare. The Synaptic Health Alliance pilot has been a cue about blockchain’s future in healthcare. Led by healthcare giants Aetna, Ascension, Humana, MultiPlan, Optum, UnitedHealthcare, and Quest Diagnostics, the program plans to use blockchain to reduce administrative costs and improve data quality. Early this year, other big-time players — Aetna, Anthem, Health Care Service Corporation (HCSC), PNC Bank, and IBM — announced a new collaborative that will leverage blockchain technology to enhance interoperability and transparency in healthcare. Many smaller partnerships continue to follow suit. However, it doesn't pay to be a guinea pig.
Hc1's software employs machine learning to prevent health systems from ordering too many or too few tests, a mistake that can lead to missed diagnoses and costly procedures.
According to a new analysis by Quest Diagnostics, one-third of U.S. industry sectors experienced year-over-year double-digit increases in workforce drug positivity between 2015 and 2018, with marijuana as the most commonly detected drug. The Quest Diagnostics Drug Testing Index is an analysis of more than 14 million urine drug tests of the general U.S. workforce in 17 different sectors.
Quest Diagnostics, through its Cleveland HeartLab subsidiary, has entered into an agreement to purchase for $8.5 million certain assets of bankrupt testing firm True Health Diagnostics.
Michigan is preparing to usher in a new era with legal recreational marijuana sales in 2020, but the state's largest employers say their pre-employment drug screenings that include cannabis will not change. The state's residents already are failing pre-employment drug screening tests at a rate higher than elsewhere in the nation. According to Quest Diagnostics data, the numbers of people who didn't pass pre-employment drug screenings and likely lost potential job opportunities has increased by 31% from 2014 to 2018, and jumped more than 20% between 2017 and 2018, alone. A Quest Diagnostics scientist said the numbers suggest a spike in marijuana use.